FDA.reportPublic FDA data

motixafortide 62 MG Injection [Aphexda]

RxCUI
2664906
RxNorm name
motixafortide 62 MG Injection [Aphexda]
Display name
motixafortide 62 MG Injection [Aphexda]
Full name
motixafortide 62 MG Injection [Aphexda]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
APHEXDAMOTIXAFORTIDEGamida Cell Inc.e704b2db-f119-40ba-9346-9229e3281c9e2026-06-04Warnings, Adverse reactionsExact identifier
rxcui: 2664906
AphexdaMOTIXAFORTIDEBioLineRx USA Incf7cdc584-ebf0-a68e-e053-6294a90a9ea92024-10-10Warnings, Adverse reactionsExact identifier
rxcui: 2664906

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e704b2db-f119-40ba-9346-9229e3281c9emotixafortide 62 MG Injection [Aphexda]SBD4These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA ® (motixafortide) for injection, for subcutaneous use Initial U.S. Approval: 202320251028
e704b2db-f119-40ba-9346-9229e3281c9eAphexda 62 MG (as motixafortide acetate) InjectionSY4These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA ® (motixafortide) for injection, for subcutaneous use Initial U.S. Approval: 202320251028
e704b2db-f119-40ba-9346-9229e3281c9eAphexda 62 MG InjectionSY4These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA ® (motixafortide) for injection, for subcutaneous use Initial U.S. Approval: 202320251028
e704b2db-f119-40ba-9346-9229e3281c9eAPHEXDA 62 MG InjectionPSN4These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA ® (motixafortide) for injection, for subcutaneous use Initial U.S. Approval: 202320251028
f7cdc584-ebf0-a68e-e053-6294a90a9ea9motixafortide 62 MG Injection [Aphexda]SBD2HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA TM (motixafortide) for injection, for subcutaneous use. Initial U.S. Approval: 202320241010
f7cdc584-ebf0-a68e-e053-6294a90a9ea9Aphexda 62 MG InjectionSY2HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA TM (motixafortide) for injection, for subcutaneous use. Initial U.S. Approval: 202320241010
f7cdc584-ebf0-a68e-e053-6294a90a9ea9Aphexda 62 MG (as motixafortide acetate) InjectionSY2HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA TM (motixafortide) for injection, for subcutaneous use. Initial U.S. Approval: 202320241010
f7cdc584-ebf0-a68e-e053-6294a90a9ea9APHEXDA 62 MG InjectionPSN2HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APHEXDA safely and effectively. See full prescribing information for APHEXDA. APHEXDA TM (motixafortide) for injection, for subcutaneous use. Initial U.S. Approval: 202320241010